Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-20

Clinical Trial Update: Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the side effects and benefits of RAS 130 in type 2 diabetes mellitus, studied with and without diet and exercise.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RAS 130

Snippet

Sponsor: American Scitech International | Conditions: Type II Diabetes Mellitus | Phase 2 | Status: UNKNOWN